PLSG Invests $450,000 in Three Companies
PITTSBURGH, Aug. 21 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the private/public partnership putting the region's life sciences industry on a fast track for growth, announced that the PLSG has invested a total of $450,000 in three companies: Applied Computational Technologies, Separation Design Group and ThermalTherapeutics Systems.
"PLSG is committed to identifying and making investments in promising life sciences technologies," said John W. Manzetti, PLSG's President & CEO. Mr. Manzetti continued, "Applied Computational Technologies (AppCompTech), Separation Design Group (SDG) and ThermalTherapeutics Systems (TTS) are three of the compelling companies that PLSG has been working with through our Concept to Commercialization(TM) model. We are excited to add SDG and TTS as new PLSG investment portfolio companies and we are very pleased to continue our support of AppCompTech's product development efforts to commercialize their technology."
The PLSG's $100,000 investment in Separation Design Group will help SDG create a prototype medical oxygen concentrator while also developing smaller, more robust adsorbents; and reducing or eliminating the moisture from the adsorbent package. This product has the potential to revolutionize the entire portable medical oxygen market and significantly improve patient care.
Currently, available portable oxygen systems are too heavy, too noisy, or do not operate long enough without recharging/refilling to facilitate the prescribed therapy. The SDG product will improve the Portable Oxygen Concentrator (POC) technology and minimize the size of the device, vastly improving a patient's overall quality of life and maintain active lifestyles.
The PLSG's $150,000 investment in Applied Computational Technologies
will enable the company to propel their product ProACTive(TM) into the
marketplace. ProACTive(TM), is AppCompTech's revolu
|SOURCE Pittsburgh Life Sciences Greenhouse|
Copyright©2007 PR Newswire.
All rights reserved